FIELD: biochemistry.
SUBSTANCE: invention relates to tricyclic compounds of formula (I) as well as their pharmaceutically acceptable salts.
EFFECT: new compounds, as well as pharmaceutical compositions based on them, and methods of treating neurological and/or mental disorders associated with dysfunction of the muscarinic acetylcholine receptor have been obtained.
21 cl, 11 tbl, 12 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
CERTAIN CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2014 |
|
RU2718876C2 |
SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
PHOSPHOINOSITIDE3-KINASE INHIBITING COMPOUNDS AND METHODS FOR USE THEREOF | 2007 |
|
RU2470936C2 |
PYRIDINES, PYRIMIDINES AND PYRAZINES AS BRUTON'S TYROSINE KINASE INHIBITORS AND USE THEREOF | 2014 |
|
RU2712220C2 |
THIAZOLOPYRIMIDINONES AS MODULATORS OF NMDA RECEPTOR ACTIVITY | 2014 |
|
RU2703273C2 |
DERIVATIVES OF N-(IMIDAZOPYRIMIDIN-7-YL)-HETEROARYLAMIDES AND THEREOF APPLICATION AS PDE10A INHIBITORS | 2011 |
|
RU2562066C2 |
NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2018 |
|
RU2785126C2 |
COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE | 2013 |
|
RU2666146C2 |
DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
Authors
Dates
2021-07-06—Published
2017-06-22—Filed